Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

Huber, Marie L; Haynes, Laura; Parker, Chris; Iversen, Peter

Huber, Marie L; Haynes, Laura; Parker, Chris; Iversen, Peter.

J Natl Cancer Inst ; 104(4): 273-9, 2012 Feb 22.

Article in En | MEDLINE | ID: mdl-22232132

Subject(s)

Aging; Cancer Vaccines/therapeutic use; Immunotherapy/methods; Neoplasms, Hormone-Dependent/drug therapy; Prostatic Neoplasms/drug therapy; Protein Tyrosine Phosphatases/metabolism; Tissue Extracts/therapeutic use; Acid Phosphatase; Age Factors; Aged; Aged, 80 and over; Cancer Vaccines/adverse effects; Clinical Trials as Topic; Humans; Immunotherapy/adverse effects; Male; Middle Aged; Neoplasms, Hormone-Dependent/immunology; Neoplasms, Hormone-Dependent/mortality; Patient Selection; Prognosis; Prostatic Neoplasms/immunology; Prostatic Neoplasms/mortality; Research Design; Survival Analysis; Tissue Extracts/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Tissue Extracts / Aging / Protein Tyrosine Phosphatases / Cancer Vaccines / Immunotherapy / Neoplasms, Hormone-Dependent Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2012 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google